407 related articles for article (PubMed ID: 30852476)
21. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles.
Xie S; Wang S; Zhao B; Han C; Wang M; Zhou W
Colloids Surf B Biointerfaces; 2008 Dec; 67(2):199-204. PubMed ID: 18829272
[TBL] [Abstract][Full Text] [Related]
22. Solid lipid nanoparticles for thermoresponsive targeting: evidence from spectrophotometry, electrochemical, and cytotoxicity studies.
Rehman M; Ihsan A; Madni A; Bajwa SZ; Shi D; Webster TJ; Khan WS
Int J Nanomedicine; 2017; 12():8325-8336. PubMed ID: 29200845
[TBL] [Abstract][Full Text] [Related]
23. Optimization of process variables of zanamivir-loaded solid lipid nanoparticles and the prediction of their cellular transport in Caco-2 cell model.
Shi LL; Cao Y; Zhu XY; Cui JH; Cao QR
Int J Pharm; 2015 Jan; 478(1):60-69. PubMed ID: 25448568
[TBL] [Abstract][Full Text] [Related]
24. Feasibility of haloperidol-anchored albumin nanoparticles loaded with doxorubicin as dry powder inhaler for pulmonary delivery.
Varshosaz J; Hassanzadeh F; Mardani A; Rostami M
Pharm Dev Technol; 2015 Mar; 20(2):183-96. PubMed ID: 24219091
[TBL] [Abstract][Full Text] [Related]
25. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics.
Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C
Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995
[TBL] [Abstract][Full Text] [Related]
26. Microwave-assisted formulation of solid lipid nanoparticles loaded with non-steroidal anti-inflammatory drugs.
Shah RM; Eldridge DS; Palombo EA; Harding IH
Int J Pharm; 2016 Dec; 515(1-2):543-554. PubMed ID: 27789371
[TBL] [Abstract][Full Text] [Related]
27. Bovine Serum Albumin (BSA) coated iron oxide magnetic nanoparticles as biocompatible carriers for curcumin-anticancer drug.
Nosrati H; Sefidi N; Sharafi A; Danafar H; Kheiri Manjili H
Bioorg Chem; 2018 Feb; 76():501-509. PubMed ID: 29310081
[TBL] [Abstract][Full Text] [Related]
28. Development and Characterization of Florfenicol-Loaded BSA Nanoparticles as Controlled Release Carrier.
Arriagada F; Günther G; Zabala I; Rubio-Retama J; Morales J
AAPS PharmSciTech; 2019 May; 20(5):202. PubMed ID: 31140015
[TBL] [Abstract][Full Text] [Related]
29. Pulmonary Delivery of Proteins Using Nanocomposite Microcarriers.
Alfagih I; Kunda N; Alanazi F; Dennison SR; Somavarapu S; Hutcheon GA; Saleem IY
J Pharm Sci; 2015 Dec; 104(12):4386-4398. PubMed ID: 26505151
[TBL] [Abstract][Full Text] [Related]
30. Solid lipid nanoparticles for transdermal delivery of avanafil: optimization, formulation, in-vitro and ex-vivo studies.
Kurakula M; Ahmed OA; Fahmy UA; Ahmed TA
J Liposome Res; 2016 Dec; 26(4):288-96. PubMed ID: 26784833
[TBL] [Abstract][Full Text] [Related]
31. Optimization of physicochemical parameters influencing the fabrication of protein-loaded chitosan nanoparticles.
Vandana M; Sahoo SK
Nanomedicine (Lond); 2009 Oct; 4(7):773-85. PubMed ID: 19839813
[TBL] [Abstract][Full Text] [Related]
32. Fabrication and Characterization of Pectin Films Containing Solid Lipid Nanoparticles for Buccal Delivery of Fluconazole.
Hirun N; Mahadlek J; Limmatvapirat S; Sriamornsak P; Yonemochi E; Furuishi T; Kraisit P
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791451
[TBL] [Abstract][Full Text] [Related]
33. Candesartan cilexetil loaded solid lipid nanoparticles for oral delivery: characterization, pharmacokinetic and pharmacodynamic evaluation.
Dudhipala N; Veerabrahma K
Drug Deliv; 2016; 23(2):395-404. PubMed ID: 24865287
[TBL] [Abstract][Full Text] [Related]
34. Preparation, characterization and in vitro cytotoxicity of Fenofibrate and Nabumetone loaded solid lipid nanoparticles.
Kumar R; Singh A; Sharma K; Dhasmana D; Garg N; Siril PF
Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110184. PubMed ID: 31753394
[TBL] [Abstract][Full Text] [Related]
35. Development characterization and skin permeating potential of lipid based novel delivery system for topical treatment of psoriasis.
Pradhan M; Singh D; Singh MR
Chem Phys Lipids; 2015 Feb; 186():9-16. PubMed ID: 25447290
[TBL] [Abstract][Full Text] [Related]
36. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
Ye J; Wang Q; Zhou X; Zhang N
Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
[TBL] [Abstract][Full Text] [Related]
37. Preformulation, Characterization, and
Algul D; Duman G; Ozdemir S; Acar ET; Yener G
J Cosmet Sci; 2018; 69(3):165-173. PubMed ID: 30052191
[TBL] [Abstract][Full Text] [Related]
38. Optimization and characterization of ultrasound assisted preparation of curcumin-loaded solid lipid nanoparticles: Application of central composite design, thermal analysis and X-ray diffraction techniques.
Behbahani ES; Ghaedi M; Abbaspour M; Rostamizadeh K
Ultrason Sonochem; 2017 Sep; 38():271-280. PubMed ID: 28633826
[TBL] [Abstract][Full Text] [Related]
39. Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells.
Vieira AC; Chaves LL; Pinheiro M; Ferreira D; Sarmento B; Reis S
Int J Nanomedicine; 2016; 11():2601-17. PubMed ID: 27354792
[TBL] [Abstract][Full Text] [Related]
40. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride.
Vaghasiya H; Kumar A; Sawant K
Eur J Pharm Sci; 2013 May; 49(2):311-22. PubMed ID: 23557842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
